e-learning
resources
Berlin 2001
Monday 24.09.2001
What can treatment of TB achieve?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment of ulcerative endobronchial tuberculosis and bronchial stenosis with aerosolized streptomycin and steroids
E. Sugihara, Y. Kido, N. Hirota, T. Rikimaru, K. Oizumi (Kurume, Japan)
Source:
Annual Congress 2001 - What can treatment of TB achieve?
Session:
What can treatment of TB achieve?
Session type:
Poster Discussion
Number:
2246
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Sugihara, Y. Kido, N. Hirota, T. Rikimaru, K. Oizumi (Kurume, Japan). Treatment of ulcerative endobronchial tuberculosis and bronchial stenosis with aerosolized streptomycin and steroids. Eur Respir J 2001; 16: Suppl. 31, 2246
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
3D-CT evaluation of endobronchial tuberculosis during aerosol therapy with corticosteroid and streptomycin
Source: Eur Respir J 2005; 26: Suppl. 49, 710s
Year: 2005
Endoscopic treatment of fistular bronchial tuberculosis
Source: Annual Congress 2009 - Clinical tuberculosis
Year: 2009
Prevalence of bronchial asthma among pulmonary TB cases and impact of basic therapy of bronchial asthma on bronchial obstruction in pulmonary TB cases
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010
Treatment of hemoptysis in inoperable patients with pulmonary aspergilloma: Value of percutaneous instillation of fluconazole
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
Intrabronchial voriconazole instillation provides effective hemoptysis control in inoperable pulmonary aspergilloma
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016
Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD
Source: Eur Respir J 2009; 34: 1066-1071
Year: 2009
Efficacy and safety of bronchial artery embolization for the control of hemoptysis in patients with mycobacterium avium complex lung disease
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Bronchial granulomas in tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 688s
Year: 2005
Factors relevant to bronchostenosis after treatment of endobronchial tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 690s
Year: 2005
Implementation of the autoangiotransplant for post-resection bronchial fistulae prevention among patients with pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 424s
Year: 2005
Intravenous ozon in pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 650s
Year: 2005
Comparison of prednisolone and budesonide in the treatment of pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 80s
Year: 2005
Incidence of mycobacterium tuberculosis in patients with bronchial anthracofibrosis
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010
Treatment results of cases of severe pulmonary tuberculosis with using rifabutin
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001
Surgical treatment of pulmonary tuberculosis
Source: Eur Respir Monogr 2013; 61: 20-36
Year: 2013
Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy
Source: Eur Respir J 2005; 25: 324-328
Year: 2005
Safety aspects of endobronchial valve application in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012
Valvular bronchial blocking in the treatment of cavitary pulmonary tuberculosis (CPTB)
Source: International Congress 2016 – Bronchoscopy: from diagnostic to treating air leaks
Year: 2016
Surgical treatment of first-found destructive pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept